Farallon Capital Management »

Mobia Med shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Mobia Med shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Mobia Med

Tip: Access up to 7 years of quarterly data

All positions including Mobia Med held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mobia Med by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 1.1M 13.40

More positions owned by Farallon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Electronic Arts (EA)
Bridgebio Pharma (BBIO)
Protagonist Therapeutics (PTGX)
Exelixis (EXEL)
Liquidia Corporation Com New (LQDA)
Amazon (AMZN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Natera (NTRA)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Roivant Sciences SHS (ROIV)
Aon Shs Cl A (AON)
Boston Scientific Corporation (BSX)

View all positions for Farallon Capital Management

Top funds holding Mobia Med

Sr One Capital Management
Farallon Capital Management
Avidity Partners Management
Deerfield Management Company
Standard Life Aberdeen
Perceptive Advisors
Vanguard Capital Management
Rock Springs Capital Management
Balyasny Asset Management
Integral Health Asset Management
Schonfeld Strategic Advisors
Geode Capital Management
Ghisallo Capital Management
Bellevue Group
LMR Partners

View all funds holding Mobia Med